HHS Restructuring and Organizational Streamlining

The U.S. Department of Health and Human Services (HHS) announced significant organizational changes.

Key Highlights of the HHS Restructuring:

Organizational Transformation

• Workforce reduced from 82,000 to 62,000 employees
• Divisions consolidated from 28 to 15
• Regional offices reduced from 10 to 5
• Centralization of key administrative functions

Specific Agency Impacts

FDA Restructuring:

• Workforce reduction of approximately 3,500 employees
• Streamlining of operations and administrative functions
• Critical assurances: No reduction in drug, medical device, or food reviewers
• No impact on inspector personnel

Additional Key Developments:

• Creation of a new Administration for a Healthy America Again (AHA)
• New Assistant Secretary for Enforcement to enhance oversight
• Establishment of an Office of Strategy to inform policy decisions

The restructuring is designed to:

• Improve operational efficiency
• Reduce administrative redundancies
• Maintain critical health service capabilities
• Implement strategic health initiatives

We will continue to monitor these changes and their potential implications for our collaborative work. 

Read HHS Fact Sheet – https://www.hhs.gov/about/news/hhs-restructuring-doge-fact-sheet.html